Novavax ($NVAX) Insider Trading & Smart Money Activity
Novavax, Inc. ($NVAX) has 13 insider trades and 2 13F position changes on file. Insiders filed 13 Form 4 transactions in the last 12 months, none of them open-market purchases or sales.
- Insider buyers (12 mo)
- 0
- Insider sellers (12 mo)
- 0
- Net insider $ (12 mo)
- $0
- Congress trades (12 mo)
- 0
- 13F moves on file
- 2
- Analyst ratings on file
- 0
NVAX insider buying and selling by quarter
| Quarter | Insider buys | Insider sales | Congress buys / sales | 13F added / cut |
|---|---|---|---|---|
| Q1 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q2 2026 | 0 | 0 | 0 / 0 | 2 / 0 |
| Q3 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q4 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.
All NVAX insider, congress, 13F and analyst activity
| Date | Source | Who | Action | Shares | Value / amount | ΔOwn | 1W | 1M | 6M | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Insider | Richard Rodgers | Sell (Option exercise) | 18.88K sh | +4.0% | -12.4% | — | |||||
| Insider | Richard Rodgers | Buy (Option exercise) | 18.88K sh | +4.0% | -12.4% | — | |||||
| Insider | David Mott | Sell (Option exercise) | 18.88K sh | +4.0% | -12.4% | — | |||||
| Insider | David Mott | Buy (Option exercise) | 18.88K sh | +4.0% | -12.4% | — | |||||
| Insider | Margaret Mcglynn | Sell (Option exercise) | 18.88K sh | +4.0% | -12.4% | — | |||||
| Insider | Margaret Mcglynn | Buy (Option exercise) | 18.88K sh | +4.0% | -12.4% | — | |||||
| Insider | Rachel King | Sell (Option exercise) | 18.88K sh | +4.0% | -12.4% | — | |||||
| Insider | Rachel King | Buy (Option exercise) | 18.88K sh | +4.0% | -12.4% | — | |||||
| Insider | Richard Douglas | Sell (Option exercise) | 18.88K sh | +4.0% | -12.4% | — | |||||
| Insider | Richard Douglas | Buy (Option exercise) | 18.88K sh | +4.0% | -12.4% | — | |||||
| Insider | Gregg Alton | Sell (Option exercise) | 18.88K sh | +4.0% | -12.4% | — | |||||
| Insider | Gregg Alton | Buy (Option exercise) | 18.88K sh | +4.0% | -12.4% | — | |||||
| Insider | Charles Newton | Buy (Grant or award) | 21.27K sh | -6.2% | -13.7% | Read | |||||
| 13F | Coatue Management | New | +3.84M sh | $34.07M | +1.7% | +1.7% | — | ||||
| 13F | Coatue Management | New | +3.84M sh | $36.14M | +1.7% | +1.7% | Read |
1W / 1M / 6M = how NVAX moved from the trade or filing date.
Insider trading in NVAX: who is buying and selling
| Insider | Role | Trades | Open-market net | Shares held | Last trade |
|---|---|---|---|---|---|
| Richard Rodgers | 2 | — | Jun 20, 2026 | ||
| David Mott | 2 | — | Jun 20, 2026 | ||
| Margaret Mcglynn | 2 | — | Jun 20, 2026 | ||
| Rachel King | 2 | — | Jun 20, 2026 | ||
| Richard Douglas | 2 | — | Jun 20, 2026 | ||
| Gregg Alton | 2 | — | Jun 20, 2026 | ||
| Charles Newton | 1 | — | Jun 18, 2026 |
Institutions moving NVAX (13F)
Frequently asked questions
What is the latest insider trade in NVAX?
Richard Rodgers filed a sell (option exercise) of 18.88K sh on Jun 20, 2026.
Which institutions changed their NVAX positions?
Recent 13F filers moving the stock include Coatue Management.
Other biotechnology stocks
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.